Summit Royalties Ltd. (the "Corporation" or "Summit") is pleased to provide a corporate update for 2025 and highlight upcoming 2026 catalysts. All amounts in US$ unless otherwise noted. Drew Clark, ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued ...
Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 - -- Expects to initiate global Phase 1/2 MAD clinical study ...
El Mundo on MSNOpinion
Laurent Richard: "We are witnessing the normalization of the assassination of journalists"
The French journalist, recognized in the 'Press Freedom' category, founded Forbidden Stories eight years ago, a consortium to ...
Tisento Therapeutics today announced that the global Phase 2b PRIZM study is fully enrolled. PRIZM is evaluating zagociguat – a once-daily, oral investigational medicine – as a treatment for the rare ...
High school is a period of life that most of us have experienced at some point in the past, present, or future. And while it ...
Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 –-- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback